Synthetic cannabidiol, the main nonpsychoactive component of cannabis, has been shown to kill the bacteria responsible for gonorrhoea, meningitis and legionnaires disease, and could lead to the to the first new class of antibiotics for resistant bacteria in 60 years.
Synthetic cannabidiol, the main nonpsychoactive component of cannabis, has been shown to kill the bacteria responsible for gonorrhoea, meningitis and legionnaires disease, and could lead...